A₁adenosine receptor agonists and their potential therapeutic applications

This publication has 54 references indexed in Scilit:

• A₁adenosine receptor partial agonist lowers plasma FFA and improves insulin resistance induced by high-fat diet in rodents
  American Journal of Physiology-Endocrinology and Metabolism, 2007
• Antilipolytic Activity of a Novel Partial A1 Adenosine Receptor Agonist Devoid of Cardiovascular Effects: Comparison with Nicotinic Acid
  The Journal of Pharmacology and Experimental Therapeutics, 2007
• N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists
  Bioorganic & Medicinal Chemistry Letters, 2007
• Tecadenoson
  Cardiology in Review, 2005
• Trial to Evaluate the Management of Paroxysmal Supraventricular Tachycardia During an Electrophysiology Study With Tecadenoson
  Circulation, 2005
• Effect of γ-butyrobetaine on fatty liver in juvenile visceral steatosis mice
  Journal of Pharmacy and Pharmacology, 2001
• A MODIFICATION OF RECEPTOR THEORY
  British Journal of Pharmacology, 1997
• In vitro effect of adenosine agonist GR79236 on the insulin sensitivity of glucose utilisation in rat soleus and human rectus abdominus muscle
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
• Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain
  Pain, 1995
• Desensitization of adenosine receptor-mediated inhibition of lipolysis. The mechanism involves the development of enhanced cyclic adenosine monophosphate accumulation in tolerant adipocytes.
  Journal of Clinical Investigation, 1986